The iCubate iC-GPC Assay™ is a multiplexed, in vitro diagnostic test for the rapid detection and identification of potentially pathogenic gram positive bacteria, which may cause bloodstream infection (BSI) and subsequent sepsis. Sepsis and the ensuing complications are now the 10th leading cause of death in the U.S. Traditional culture techniques may require 2-4 days to identify both the causative organism and resistance profile, resulting in delayed treatment and increased costs. The iC-GPC Assay™ provides bacterial identification and resistance determination from positive blood cultures up to 48 hours faster than conventional methods, improving time to treatment and patient outcomes. The iC-GPC Assay™ detects five of the most common gram positive organisms associated with BSI as well as three clinically significant resistance markers:
|Bacterial Species||Resistance Markers|
|mecA– associated with methicillin resistance
vanA- associated with vancomycin resistance
vanB– associated with vancomycin resistance
Join the iC-Community™ to get the latest updates from our dedicated team and learn more about molecular diagnostics!
601 Genome Way,
Suite 3005, Huntsville, AL 35806